Xeltis’ CTO and Co-Founder Martijn Cox will present insights on the XABG device, the company’s restorative coronary artery bypass graft, at 2021 Vascular Biology meeting organized by the North American Vascular Biology Organization (NAVBO).
Martijn’s presentation “Clinical translation of restorative polymer-based small diameter vessels”, will be part of a symposium on vascular therapeutics taking place on October 29th at 10:15 ET, also featuring research from Yale School of Medicine and Nationwide Children’s Hospital.
Xeltis has been invited to share its work alongside other industrial and academic leaders working on clinical translation of novel cardiovascular grafts (blood vessels). NAVBO provides a forum for members to disseminate and share knowledge related to the scientific field of vascular biology, to ensure the translation of knowledge from basic science to clinical practice.
Now in its 35th edition, EACTS annual meeting is the largest event for the cardiothoracic community in Europe.
